NLRP3 and Alzheimer disease: The DNCB-induced AD model demonstrated a notable increase in the count of cells positive for NLRP3 and F4/80, whereas administration of 1% MAEO significantly attenuated NLRP3-expressing macrophages (Figure 3C).